Dr Greg Fox is a respiratory physician and epidemiologist from Sydney University, with a research interest in lung health in resource-limited settings. He lived in Vietnam for 4 years, establishing multi-centre studies to enhance case detection for tuberculosis. He has continued his collaboration with research partners in Vietnam, leading studies in the management of chronic lung disease and drug resistant tuberculosis. He works clinically at Royal Prince Alfred Hospital in Sydney.
Publication date: 21 March 2017
Evon Okidi is a Biostatistician at the Academic Model Providing Access to Healthcare (AMPATH) research centre. She received her Sc.M. in Biostatistics from Brown University where she did research on missing data methods in a hypertensive HIV infected population. She has since been working on chronic diseases research, primarily hypertension and diabetes studies, for over two years. Her research interests are in missing data and causal inference methods.
Publication date: 12 December 2016
Deksha Kapoor is a Research Scientist at the Department of Endocrinology and Metabolism, All India Institute of Medical Sciences (AIIMS), India. She has been involved with various multi-site research projects with key emphasis in the area of chronic diseases. AIIMS in collaboration with the George Institute of Global Health, was awarded the GACD grant to carry out a study on the "LIVING- Lifestyle InterVention IN Gestational Diabetes” specifically in India, Sri Lanka and Bangladesh.
Publication date: 14 November 2016
Esteve Fernández is the Director of the Tobacco Control Unit and WHO Collaborating Centre for Tobacco Control, Catalan Institute of Oncology. He is also Professor of Epidemiology at the School of Medicine, University of Barcelona. Esteve has worked on cancer epidemiology, especially in the area of tobacco control, as well as in cancer incidence and mortality analysis. He has served as Editor in Chief of Gaceta Sanitaria (the Spanish journal of public health) and as President of the Spanish Society of Epidemiology.
Publication date: 30 August 2016
Kamran Siddiqi is a clinical academic with an international reputation for leading high quality research in the field of lung health. In the last 10 years, he has secured £4.9 million in research income as Principal Investigator and another £9.3 million as co-Investigator. Kamran has published extensively in the field of TB and tobacco control. He was recently elected to serve as the chair of the tobacco section and as a board member of the International UNION against TB and Lung Diseases.
Publication date: 9 August 2016
“Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme”
Publication date: 29 July 2016